vimarsana.com
Home
Live Updates
Dr Leick on Limitations Associated With CAR T-Cell Therapy in Hematologic Malignancies : vimarsana.com
Dr Leick on Limitations Associated With CAR T-Cell Therapy in Hematologic Malignancies
Mark Leick, MD, discusses the challenges and limitations associated with the use of CAR T-cell therapy across hematologic malignancies, highlighting how ongoing research may potentially ameliorate present unmet needs.
Related Keywords
Massachusetts ,
United States ,
Mark Leick ,
Research Institute ,
Groupc Monthly ,
Harvard Medical School ,
Stanford University ,
Massachusetts General Research Institute ,
Massachusetts General Hospital ,
Cart Cell Therapy ,
B Cell Lymphoma ,
Elderly Or Frail Patients ,
vimarsana.com © 2020. All Rights Reserved.